Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,601–5,625 of 7,816 matching trials · page 225 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Interactive Stepping Exercise on Memory NCT04103463 Interactive stepping exercise; Home exercise |
NA other |
UNKNOWN | 30 | National Yang Ming Chiao Tung University OTHER |
2019-09-25 |
|
Cognitive Training Using Feuerstein Instrumental Enrichment NCT02774083 Feuerstein Program; Adler Program Runs in: Israel · 5 sites |
NA other |
COMPLETED | 26 | Rambam Health Care Campus OTHER |
2019-09-24 |
|
Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG) NCT01868165 Runs in: United Kingdom · 7 sites |
NA other |
COMPLETED | 337 | Imperial College London OTHER |
2019-09-23 |
|
Reducing Agitation in People With Dementia: the Customized Activity Trial NCT01892579 Tailored Activity Program; Home Safety and Education Program Runs in: United States · 1 site |
NA other |
COMPLETED | 250 | Johns Hopkins University OTHER |
2019-09-23 |
|
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Mild Cognitive Impairment NCT03647345 High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC; High-... Runs in: South Korea · 1 site |
NA other |
COMPLETED | 21 | Samsung Medical Center OTHER |
2019-09-20 |
|
Apolipoprotein E Gene and Functional MRI NCT01287819 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 200 | Taipei Medical University Shuang Ho Hospital OTHER |
2019-09-19 |
|
Amyloid Accumulation After Mild Traumatic Brain Injury NCT02134041 traumatic brain injury Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 150 | Taipei Medical University Shuang Ho Hospital OTHER |
2019-09-19 |
|
Efficacy Study of Yi-Zhi-An-Shen Granules For Older Adults With Amnestic Mild Cognitive Impairment NCT03601000 Yi-Zhi-An-Shen; Placebo Runs in: China · 2 sites |
PHASE1|PHASE2 other |
COMPLETED | 80 | Chengdu University of Traditional Chinese Medicine OTHER |
2019-09-19 |
|
Using Emotion Regulation to Decrease Aggression in Veterans With PTSD NCT02724787 Manage Emotions to Reduce Aggression (MERA) Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | VA Office of Research and Development OTHER_GOV |
2019-09-17 |
|
Functional MRI Changes Resulting From the Feuerstein Program in Older People With Mild Cognitive Impairment (MCI) NCT03447236 Feuerstein Program Runs in: Israel · 1 site |
NA other |
COMPLETED | 28 | Rambam Health Care Campus OTHER |
2019-09-17 |
|
RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia NCT03923517 RHAPSODY online program and MEET online sessions Runs in: Germany · 1 site |
NA other |
COMPLETED | 20 | Technical University of Munich OTHER |
2019-09-17 |
|
A Safety Study of LY2886721 Single Doses in Healthy Subjects NCT01133405 LY2886721; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 40 | Eli Lilly and Company INDUSTRY |
2019-09-16 |
|
Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset NCT01931566 Pioglitazone; Pioglitazone placebo Runs in: Australia; Germany; Switzerland; United Kingdom; United States · 55 sites |
PHASE3 other |
TERMINATED | 3,494 | Takeda INDUSTRY |
2019-09-16 |
|
Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC) NCT03485898 Runs in: France · 1 site |
NA other |
TERMINATED | 58 | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer OTHER |
2019-09-16 |
|
Efficacy and Safety of SOM3355 in Huntington's Disease Chorea NCT03575676 SOM3355 100mg BID; SOM3355 200mg BID; Placebo BID Runs in: Spain · 4 sites |
PHASE2 other |
COMPLETED | 32 | SOM Innovation Biotech SA INDUSTRY |
2019-09-16 |
|
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia NCT02333942 Nautilus NeuroWaveTM System Runs in: United States · 1 site |
NA other |
COMPLETED | 41 | Jan Medical, Inc. INDUSTRY |
2019-09-13 |
|
Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone NCT03762902 Runs in: United States · 2 sites |
NA other |
TERMINATED | 10 | Lifegraph Ltd. INDUSTRY |
2019-09-13 |
|
NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. NCT02703636 Rivastigmine Patch Runs in: Japan · 19 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 118 | Novartis Pharmaceuticals INDUSTRY |
2019-09-12 |
|
Brain Vascular Disease in Aging and Dementia NCT03075007 Florbetaben F18; Transcranial Doppler Runs in: United States · 1 site |
NA other |
COMPLETED | 48 | Columbia University OTHER |
2019-09-12 |
|
Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium NCT02118688 Risperidone; Trazodone; Placebo Runs in: United States · 1 site |
PHASE4 other |
WITHDRAWN | 0 | Rochester General Hospital OTHER |
2019-09-10 |
|
Safety, Tolerability, and Pharmacokinetics Study of NDX-1017 NCT03298672 NDX-1017; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 88 | LeonaBio INDUSTRY |
2019-09-10 |
|
The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE) NCT03692182 Runs in: United States · 1 site |
NA other |
COMPLETED | 10,000 | Tabula Rasa HealthCare INDUSTRY |
2019-09-10 |
|
Cerebral and Peripheral Perfusion Pilot Study NCT00751907 atorvastatin; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 16 | University of Wisconsin, Madison OTHER |
2019-09-09 |
|
Cognitive Impairment in Atrial Fibrillation NCT01816308 Runs in: United States · 1 site |
NA other |
UNKNOWN | 888 | Texas Cardiac Arrhythmia Research Foundation OTHER |
2019-09-09 |
|
Preventing Violence Among Veterans in Substance Use Disorder Treatment NCT01337973 MI-CBT; MI-CBT+CC; E-TAU Runs in: United States · 1 site |
NA other |
COMPLETED | 180 | VA Office of Research and Development OTHER_GOV |
2019-09-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial